Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Etoposide | 0.01 | uM | 2 | 625.00 | 277.50 | 3408.00 | 4148.50 | 0.8215 | 0.9017 |
MCF 10A | NVP-TAE684 | 3.1623 | uM | 2 | 625.00 | 277.50 | 233.00 | 4148.50 | 0.0562 | -0.0438 |
MCF 10A | Etoposide | 0.31623 | uM | 2 | 625.00 | 277.50 | 990.00 | 4148.50 | 0.2386 | 0.3854 |
MCF 10A | PLX-4720 | 0.0033113 | uM | 2 | 625.00 | 277.50 | 4593.00 | 4148.50 | 1.1071 | 1.0529 |
MCF 10A | NVP-TAE684 | 0.01 | uM | 2 | 625.00 | 277.50 | 3960.00 | 4148.50 | 0.9546 | 0.9763 |
MCF 10A | Etoposide | 0.0033113 | uM | 2 | 625.00 | 277.50 | 4597.00 | 4148.50 | 1.1081 | 1.0533 |
MCF 10A | PLX-4720 | 10 | uM | 2 | 625.00 | 277.50 | 3451.00 | 4148.50 | 0.8319 | 0.9078 |
MCF 10A | Etoposide | 3.1623 | uM | 2 | 625.00 | 277.50 | 204.00 | 4148.50 | 0.0492 | -0.0758 |
MCF 10A | Nilotinib | 19.9526 | uM | 2 | 625.00 | 277.50 | 307.00 | 4148.50 | 0.0740 | 0.0262 |
MCF 10A | Nilotinib | 0.1 | uM | 2 | 625.00 | 277.50 | 4735.00 | 4148.50 | 1.1414 | 1.0689 |
MCF 10A | PLX-4720 | 0.1 | uM | 2 | 625.00 | 277.50 | 4067.00 | 4148.50 | 0.9804 | 0.9899 |
MCF 10A | PLX-4720 | 1 | uM | 2 | 625.00 | 277.50 | 3940.00 | 4148.50 | 0.9497 | 0.9737 |
MCF 10A | NVP-TAE684 | 0.1 | uM | 2 | 625.00 | 277.50 | 2952.00 | 4148.50 | 0.7116 | 0.8330 |
MCF 10A | Nilotinib | 10 | uM | 2 | 625.00 | 277.50 | 918.00 | 4148.50 | 0.2213 | 0.3588 |
MCF 10A | Nilotinib | 0.01 | uM | 2 | 625.00 | 277.50 | 4001.00 | 4148.50 | 0.9644 | 0.9815 |
MCF 10A | Etoposide | 19.9526 | uM | 2 | 625.00 | 277.50 | 146.00 | 4148.50 | 0.0352 | -0.1518 |
MCF 10A | 0 | uM | 2 | 625.00 | 277.50 | 3860.00 | 4148.50 | 0.9305 | 0.9634 | |
MCF 10A | 0 | uM | 2 | 625.00 | 277.50 | 2589.00 | 4148.50 | 0.6241 | 0.7724 | |
MCF 10A | 0 | uM | 2 | 625.00 | 277.50 | 3543.00 | 4148.50 | 0.8540 | 0.9208 | |
MCF 10A | 0 | uM | 2 | 625.00 | 277.50 | 5031.00 | 4148.50 | 1.2127 | 1.1013 | |
MCF 10A | Etoposide | 1 | uM | 2 | 625.00 | 277.50 | 250.00 | 4148.50 | 0.0603 | -0.0264 |
MCF 10A | NVP-TAE684 | 0.0016596 | uM | 2 | 625.00 | 277.50 | 5091.00 | 4148.50 | 1.2272 | 1.1077 |
MCF 10A | 0 | uM | 2 | 625.00 | 277.50 | 4944.00 | 4148.50 | 1.1918 | 1.0920 | |
MCF 10A | NVP-TAE684 | 10 | uM | 2 | 625.00 | 277.50 | 217.00 | 4148.50 | 0.0523 | -0.0611 |
MCF 10A | Nilotinib | 0.0033113 | uM | 2 | 625.00 | 277.50 | 4949.00 | 4148.50 | 1.1930 | 1.0925 |